NewsRx

Search our medical news database

BG Medicine

Drug development firm participates in FDA task force

Published in Drug Law Weekly, April 5th, 2005

BG Medicine, an emerging drug development company, announced its' participation as a member of the 21st Century U.S. Food & Drug Administration (FDA) Task Force.

The task force, formed by the Manhattan Institute for Policy Research, is chaired by Robert Goldberg, PhD, director of the Institute's Center for Medical Progress. The Task Force charter originates from the FDA's publication, "Innovation or Stagnation: Challenge and Opportunity in the Critical Path to New Medical Products," published in March 2004.

The FDA Report summary states, "A new product development toolkit - containing powerful new scientific and technical methods...is urgently needed...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook